Constance Bienfait - ResMed Director Relations
| RME Stock | EUR 222.20 1.40 0.63% |
Insider
Constance Bienfait is Director Relations of ResMed Inc
| Phone | 858 836 5000 |
| Web | https://www.resmed.com |
ResMed Management Efficiency
The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Pascale Boissel | Sartorius Stedim Biotech | N/A | |
| Gary Loeb | Intuitive Surgical | N/A | |
| David Pendarvis | Resmed Inc DRC | 64 | |
| Petra Kirchhoff | Sartorius Aktiengesellschaft | 54 | |
| John Mackay | Sartorius Stedim Biotech | 61 | |
| Patricia Spannagel | Sartorius Aktiengesellschaft | N/A | |
| Marshall Mohr | Intuitive Surgical | 67 | |
| Rene Faber | Sartorius Aktiengesellschaft | 48 | |
| Robert DeSantis | Intuitive Surgical | 57 | |
| Robert Douglas | Resmed Inc DRC | 63 | |
| Brett Sandercock | Resmed Inc DRC | 56 | |
| Urvashi Tyagi | Resmed Inc DRC | N/A | |
| Amelie Buton | Sartorius Stedim Biotech | 32 | |
| Fredrik Widman | Intuitive Surgical | N/A | |
| Manohar Kuppusami | Sartorius Aktiengesellschaft | N/A | |
| Julian Nikolchev | Intuitive Surgical | 69 | |
| Rene Faber | Sartorius Stedim Biotech | 43 | |
| Philip Kim | Intuitive Surgical | N/A | |
| John Mackay | Sartorius Aktiengesellschaft | 61 | |
| Kaushik Ghoshal | Resmed Inc DRC | 55 | |
| AM AM | Resmed Inc DRC | 80 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 |
ResMed Inc Leadership Team
Elected by the shareholders, the ResMed's board of directors comprises two types of representatives: ResMed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ResMed. The board's role is to monitor ResMed's management team and ensure that shareholders' interests are well served. ResMed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ResMed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham, VP Communications | ||
| Brett Sandercock, Chief Officer | ||
| BE MBA, CEO Director | ||
| Robert Douglas, Pres COO | ||
| Vered Keisar, Chief Officer | ||
| AM AM, Founder Chairman | ||
| David Pendarvis, Global Officer | ||
| Kaushik Ghoshal, Pres Bus | ||
| Constance Bienfait, Director Relations | ||
| Urvashi Tyagi, Chief Officer |
ResMed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ResMed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.17 B | |||
| Shares Outstanding | 146.91 M | |||
| Shares Owned By Insiders | 1.29 % | |||
| Shares Owned By Institutions | 66.53 % | |||
| Price To Earning | 41.49 X | |||
| Price To Book | 9.40 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in ResMed Stock
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.